The combined presence of H pylori infection and gastro-oesophageal reflux disease leads to an up-regulation of CDX2 gene expression in antrum and cardia
- PMID: 19251954
- DOI: 10.1136/jcp.2008.060061
The combined presence of H pylori infection and gastro-oesophageal reflux disease leads to an up-regulation of CDX2 gene expression in antrum and cardia
Abstract
Background: CDX2 is an epithelial transcription factor that regulates intestinal differentiation and is involved in the development of intestinal metaplasia (IM).
Aim: To analyse the expression of CDX2 in the gastric mucosa in various locations and its relationship to Helicobacter pylori infection and gastro-oesophageal reflux disease (GORD).
Methods: 69 patients with upper gastrointestinal symptoms were stratified into four groups according to their H pylori and GORD status. Patients without infection and without GORD were the reference group (H pylori(-)/GORD(-)). Biopsies from the antrum, corpus and cardia were assessed by histopathology according to the updated Sydney System. CDX2 transcription levels were determined by quantitative RT-PCR and immunohistochemistry.
Results: CDX2 gene expression was significantly up-regulated in antral and cardia mucosa of patients with both H pylori infection and GORD (26- and 100-fold, respectively; p<0.05), but remained unchanged in corpus mucosa. If only H pylori infection or GORD was present, CDX2 expression levels were 6- to 11-fold increased in the antrum, but without reaching statistical significance. CDX2 expression correlated positively with the degree of IM (p<0.01) and the degree of H pylori induced inflammation (p<0.05). Gene expression data were confirmed immunohistochemically by the detection of CDX2 in areas of IM and in focally distributed CDX2-expressing cells in non-metaplastic gastric mucosa.
Conclusions: The combined presence of H pylori infection and GORD leads to an up-regulation of CDX2 gene expression in cardia and antral mucosa, but not in the corpus.
Similar articles
-
Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study.Dig Liver Dis. 2000 Oct;32(7):567-72. doi: 10.1016/s1590-8658(00)80837-3. Dig Liver Dis. 2000. PMID: 11142553
-
Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.Am J Gastroenterol. 1999 Nov;94(11):3175-80. doi: 10.1111/j.1572-0241.1999.01513.x. Am J Gastroenterol. 1999. PMID: 10566710
-
Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epithelium.Scand J Gastroenterol. 2008 Aug;43(8):915-21. doi: 10.1080/00365520802014841. Scand J Gastroenterol. 2008. PMID: 19086163
-
Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both.Dig Dis. 2000;18(1):14-9. doi: 10.1159/000016929. Dig Dis. 2000. PMID: 10729733 Review.
-
Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.Gut. 1999 Jul;45 Suppl 1(Suppl 1):I13-7. doi: 10.1136/gut.45.2008.i13. Gut. 1999. PMID: 10457030 Free PMC article. Review.
Cited by
-
H. pylori infection is a key risk factor for proximal gastric cancer.Dig Dis Sci. 2010 Nov;55(11):3124-31. doi: 10.1007/s10620-010-1351-x. Epub 2010 Jul 29. Dig Dis Sci. 2010. PMID: 20668939
-
Cell lineage dynamics in the process leading to intestinal metaplasia.J Gastroenterol. 2011 May;46(5):620-8. doi: 10.1007/s00535-011-0391-0. Epub 2011 Mar 8. J Gastroenterol. 2011. PMID: 21384254
-
New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):109-19. doi: 10.1007/s10911-015-9333-4. Epub 2015 Jul 21. J Mammary Gland Biol Neoplasia. 2015. PMID: 26193871 Review.
-
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.Clin Drug Investig. 2015 Oct;35(10):665-73. doi: 10.1007/s40261-015-0329-z. Clin Drug Investig. 2015. PMID: 26369655 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical